SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Nephros Inc (NEPH)

NASDAQ: NEPH · Real-Time Price · USD
3.18-0.02 (-0.62%)
 
Market Cap34.54M-38.4%
Revenue (ttm)20.72M
Net Income1.74M
EPS0.15
Shares Out10.86M
PE Ratio21.20
Forward PE15.14
Dividendn/a
Ex-Dividend Daten/a
Volume8,401
Open3.16
Previous Close3.20
Day's Range3.11 - 3.23
52-Week Range2.66 - 6.42
Beta1.64
Analystsnone
Price Target6.25(+96.54%)
Earnings DateNov 5, 2026
-0.63% (1D)
No price history available.
Insider Score
––Not scored
NEPH Insider Score

Insiders here have filed 7 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

About NEPH

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Address
380 Lackawanna Place, South Orange, NJ, 07079, United States
Market Cap
35 million
Employees
36
Industrial Classification
Medical Instruments & Supplies
1 Day
-0.62%
5 Days
-13.35%
1 Month
-29.65%
6 Months
+9.28%
1 Year
-38.37%

$NEPH stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NEPH holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NEPH's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NEPH Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New NEPH patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NEPH from public contracts

Source: USAspending.gov

NEPH Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for NEPH yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from NEPH’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.